A7FT29 AF NFT

Xanthine phosphoribosyltransferase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib5j2hrku6i6fub2t436j32ugsjfrqhkzjutc6hntp5735jrmphpu/metadata.json
IPFS of structure file: 
bafybeifbmsu4ar7cgjkqxqwtgauyruiyk4o54c5ei4ciwck6yz36a5at6e/AF-A7FT29-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9E7ae75e65F4Ff30a5677a176F6f49CDfD5a0ee4
First NFT owner address (bech32): 
genesis1neawwhn97nlnpft80gtk7m6feh745rhyttly9u
Current NFT ID #501705 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
501705
Accession (UniProt):
A7FT29
Name::
Xanthine phosphoribosyltransferase 2
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain ATCC 19397 / Type A)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7FT29 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7FT29|XPT2_CLOB1 Xanthine phosphoribosyltransferase 2 OS=Clostridium botulinum (strain ATCC 19397 / Type A) OX=441770 GN=xpt2 PE=3 SV=1 MKLLEDKILKEGILLEGNILKVDSFLNHQMDVKLFNEIGKEFKRRFEGCSINKILTIEASGIGIATIVSQYFDFCPVVFAKKVDAANMDKDTYESKVHSFTKNKTYNVRVSKKYINKGDKILLIDDFLANGCAALGLIDIIKQGGAELIGVGIAIEKGFQKGRKELEKVGAKVESLAILDKIENDKVYFK